Gene Expression in Colorectal Cancer
Author Information
Author(s): Chave H S, Gough A C, Palmer K, Preston S R, Primrose J N
Primary Institution: University Surgical Unit, Southampton General Hospital
Hypothesis
Bombesin-like peptides and their receptors may play a role in colorectal cancer.
Conclusion
The study found that gastrin releasing peptide (GRP) is more expressed in colorectal cancer tissues compared to normal mucosa, suggesting it may act as an autocrine growth factor.
Supporting Evidence
- Gastrin releasing peptide (GRP) receptor and ligand expression was present in all samples.
- Overall greater expression of GRP was found in tumor samples compared to normal mucosa.
- Neuromedin B (NMB) receptor expression was not detectable in the samples.
- NMB ligand was detected in all but one mucosal sample.
Takeaway
Researchers looked at how certain genes behave in cancer and normal tissue, finding that a specific peptide is more active in cancer.
Methodology
Expression was analyzed using reverse transcription polymerase chain reaction (RT-PCR) and in situ hybridization (ISH).
Participant Demographics
Patients included those with colorectal cancer and matched normal mucosa.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website